Related Experiment Video
Updated: Aug 15, 2026

Measurement of Smooth Muscle Function in the Isolated Tissue Bath-applications to Pharmacology Research
Published on: January 19, 2015
Interactions of putatively irreversible antagonists with beta 1- and beta 2-adrenergic receptors
Abstract:
Three compounds that have been suggested to irreversibly inactivate beta-adrenergic receptors were studied: NHNPNBE [N-(2-hydroxy-3-[1-napthoxy]-propyl)-N-bromoacetylethylenediami ne], BAAM (bromoacetylalprenololmenthane), and Ro 3-7894 [1-(5-chloracetylaminobenzfuran-2-yl)-2-isopropylaminoethanol++ +]. Membranes of rat cerebral cortex were used as a source of predominantly beta 1-adrenergic receptors and membranes of rat cerebellum were used as a source of predominantly beta 2-adrenergic receptors. Beta-Adrenergic receptor binding sites were studied by Scatchard analysis of saturation isotherms of specific [125I]-pindolol ([125I]PIN) binding. NHNPNBE added to the incubation medium competitively inhibited specific [125I]PIN binding in both cerebellum and cerebral cortex with KI values of 1-2 microM in each tissue. After washout of membranes pretreated with NHNPNBE for 30 min at 37 degrees, no loss of specific [125I]PIN binding sites was observed in either cerebellum or cortex except at very high concentrations (30-100 microM). Ro 3-7894 caused a simple competitive inhibition of specific [125I]PIN binding in rat cerebellar membranes with a KI of approximately 14 microM, an effect which was reversed completely by washing. In cerebral cortex, Ro 3-7894 added to the incubation medium apparently decreased the density of [125I]PIN binding sites with an IC50 around 1 microM. This effect was reversed after washing the membranes twice. However, in the presence of Ro 3-7894 some Scatchard plots showed a slight curvature. Further saturation of the [125I]PIN binding sites in cerebral cortex showed that the inhibition by Ro 3-7894 was competitive but with a high- and low-affinity component, consistent with Ro 3-7894 being a beta 1-selective competitive antagonist. Ro 3-7894 was also beta 1-selective in other tissues. BAAM added to the incubation medium competitively inhibited specific [125I]PIN binding in both cerebellum and cortex with KI values of 0.006 to 0.03 microM, but was about 5-fold more potent in cerebellum. After treatment of membranes with higher concentrations of BAAM for 30 min at 37 degrees and washing twice, there was a dose-dependent decrease in the density of specific [125I]PIN binding sites with IC50 values of approximately 0.3 microM in both tissues. Similar effects were observed in rat heart. These data suggest that NHNPNBE is a simple competitive antagonist at both beta 1- and beta 2-adrenergic receptors except at very high concentrations. Ro 3-7894 is a beta 1-selective competitive antagonist with no apparent irreversible effects.(ABSTRACT TRUNCATED AT 400 WORDS)
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Antihypertensive Drugs: Types of β-Blockers

